Cardiol Therapeutics Inc. (TSX:CRDL)
Canada · Delayed Price · Currency is CAD 1.810
-0.060 (-3.21%)
May 15, 2026, 4:00 PM EST
Cardiol Therapeutics Market Cap
Cardiol Therapeutics has a market cap or net worth of CAD 202.49 million as of May 19, 2026. Its market cap has increased by 61.22% in one year.
Market Cap
202.49M
Enterprise Value
174.93M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.81
Market Cap Chart
Since December 20, 2018, Cardiol Therapeutics's market cap has increased from 94.32M to 202.49M, an increase of 114.69%. That is a compound annual growth rate of 10.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 202.49M | 55.33% |
| Dec 31, 2025 | 130.36M | -13.65% |
| Dec 31, 2024 | 150.97M | 110.34% |
| Dec 29, 2023 | 71.77M | 63.28% |
| Dec 30, 2022 | 43.96M | -69.05% |
| Dec 31, 2021 | 142.02M | 55.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cipher Pharmaceuticals | 445.11M |
| TerrAscend | 294.08M |
| Aurora Cannabis | 271.98M |
| Auxly Cannabis Group | 214.86M |
| Organigram Global | 210.95M |
| Cannara Biotech | 167.93M |
| BioSyent | 166.43M |
| Ascend Wellness Holdings | 156.10M |